Filing Details

Accession Number:
0001347166-11-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-07 18:06:59
Reporting Period:
2011-06-03
Filing Date:
2011-06-07
Accepted Time:
2011-06-07 18:06:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1068796 Maxygen Inc MAXY Services-Commercial Physical & Biological Research (8731) 770449487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1101713 Gordon Ringold C/O Maxygen, Inc.
515 Galveston Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-03 10,000 $5.22 60,000 No 4 P Direct
Common Stock Acquisiton 2011-06-06 10,000 $5.27 70,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 256,496 Indirect Trust
Common Stock 63,198 Indirect By Technogen
Footnotes
  1. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $5.21 to $5.24 per share. Upon request by the Commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
  2. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $5.25 to $5.28 per share. Upon request by the Commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
  3. Gordon Ringold and Tanya Zarucki 1999 Trust
  4. The amount of securities reported consists of shares of common stock of the Company held by Technogen Enterprises, L.L.C. Dr. Ringold is a Managing Member of Technogen Enterprises, L.L.C. and has shared power to vote or direct the vote of and shared power to dispose or direct the disposition of the shares held by the limited liability company. Dr. Ringold disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in the limited liability company.